Some of the blood transport plasma proteins can also be uptaken by cancer cells via active targeting: cancer cells can selectively accumulate human serum albumin and transferrin because of the high expression levels of albumin-binding proteins (gp60 and SPARC) and transferrin receptors. Here, TFRC is linked to cancer.